• 페이스북 공유
  • 트위터 공유
  • 미투데이 공유
  • URL복사
  • 더보기
  • 관심의료진 등록

임형준

임형준

임형준 교수의 진료시간표 진료예약

진료과/센터 전문진료과목
소화기내과
오후
오전
-
오전
오전
교대진료 간염 , 간암 , 간경변증 (간경화) (홀수달 토요일 3주 진료)

임형준 교수의 상세정보

학력

more
  • 1988 .03  ~  1994 .02  :  고려대학교 의학과 의학사
  • 1996 .09  ~  1998 .08  :  고려대학교 대학원 의학과 의학석사
  • 2002 .09  ~  2005 .02  :  고려대학교 대학원 의학과 의학박사

경력

more
  • 1994 .03  ~  1995 .02  :  고려대학교 의료원 안암병원 수련의
  • 1995 .03  ~  1999 .02  :  고려대학교 의료원 구로병원 내과 전공의
  • 2002 .05  ~  2003 .02  :  고려대학교 의료원 안산병원 임상강사
  • 2003 .03  ~  2004 .02  :  고려대학교 의료원 구로병원 임상강사
  • 2004 .03  ~  2005 .02  :  고려대학교 의료원 안산병원 임상조교수
  • 2005 .03  ~  2006 .02  :  University of Michigan Research Fellow
  • 2006 .03  ~  2008 .02  :  고려대학교 의료원 안산병원 조교수
  • 2008 .03  ~  2013 .02  :  고려대학교 의료원 안산병원 부교수
  • 2012 .03  ~  2014 .02  :  고려대학교 의료원 안산병원 소화기내과장
  • 2013 .03  ~   :  고려대학교 의료원 안산병원 교수
  • 2014 .02  ~  2015 .06  :  미 국립보건연구원 (NIH, National Institute of Health) 교환교수
  • 2016 .03  ~   :  고려대학교의료원 안산병원 소화기내과장

학회활동

more
  • 1999 .02  ~   :  대한내과학회 정회원
  • 2003 .09  ~   :  대한 소화기 내시경학회 정회원
  • 2003 .09  ~   :  대한간학회 정회원
  • 2004 .09  ~   :  대한 소화기 학회 정회원
  • 2006 .03  ~  2009 .11  :  대한 간학회 보험 위원
  • 2008 .06  ~  2011 .06  :  대한 간암 연구학회 학술 위원
  • 2009 .11  ~  2013 .11  :  대한 간학회 학술 위원
  • 2011 .07  ~  2013 .07  :  대한 간암 연구학회 학술위원장
  • 2014 .07  ~  2015 .06  :  대한간암학회 총무이사
  • 2015 .07  ~   :  대한간암학회 감사

논문

more
  • [SCI] (Genotypic shift of the hepatitis A virus and its clinical impact on acute hepatitis A in Korea: a nationwide multicenter study)
  • [SCI] (Is colonoscopic screening necessary for patients with gastric adenoma or cancer?)
  • [SCI] (Low vitamin d status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults)
  • [SCI] (Role of Hepatitis B Surface Antigen (HBsAg) in Identifying True Inactive HBsAg Carriers Infected With Genotype C Hepatitis B Virus)
  • [SCI] (Systemic Cytotoxic Chemotherapy of Patients With Advanced Hepatocellular Carcinoma in the Era of Sorafenib Nonavailability)
  • [SCI] (Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization)
  • [SCI] (A nationwide seroepidemiology of hepatitis C virus infection in South Korea)
  • [SCI] (Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population)
  • [SCI] (Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis)
  • [SCI] (Current status of molecular targeted therapies in hepatocellular carcinoma)
  • [SCI] (Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial)
  • [SCI] (Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study)
  • [SCI] (Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy)
  • [SCI] (A novel estimation of the relative economic value in terms of different chronic hepatitis B treatment options)
  • [SCI] (Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B)
  • [SCI] (Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis)
  • [SCI] (Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents)
  • [SCI] (Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test)
  • [SCI] (Endoscopic treatment of duodenal bleeding caused by direct hepatocellular carcinoma invasion with an ethanol injection)
  • [SCI] (Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis)
  • [SCI] (Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study)
  • [SCI] (Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing)
  • [SCI] (Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea)
  • [SCI] (Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients)
  • [SCI] (Small bowel carcinoma in young patient detected by double-balloon enteroscopy)
  • [SCI] (Comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B virus infection: two-year follow-up data)
  • [SCI] (Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus)
  • [SCI] (Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy)
  • [SCI] (Clinical significance of the detection of antinuclear antibodies in patients with acute hepatitis a)
  • [SCI] (Duodenobronchial fistula presenting with persistent pneumonia: report of a case)
  • [SCI] (Endovascular management for isolated spontaneous dissection of the superior mesenteric artery: report of two cases and literature review)
  • [SCI] (Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study)
  • [SCI] (Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels)
  • [SCI] (The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers)
  • [SCI] (The efficacy of early scheduled follow-up endoscopic retrograde cholangiopancreatography after common bile duct stone removal)
  • [SCI] (Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients)
  • [SCI] (Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B)
  • [SCI] (Healthy range for serum ALT and the clinical significance of "unhealthy" normal ALT levels in the Korean population)
  • [SCI] (Korean Liver Cancer Study Group. A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma)
  • [SCI] (Liver cirrhosis induced by porphyria cutanea tarda: a case report and review)
  • [SCI] (Focal hepatic steatosis that appears as a liver mass in imaging)
  • [SCI] (HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma)
  • [SCI] (Validation of a Mayo post-operative mortality risk prediction model in Korean cirrhotic patients)
  • [SCI] (Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases)
  • [SCI] (Pulmonary Arteriovenous Malformation in Cryptogenic Liver Cirrhosis Associated with Turner's Syndrome)
  • [SCI] (APPROACH Working Group. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions)
  • [SCI] (Abdominal obesity as a risk factor for the development of erosive esophagitis in subjects with a normal esophago-gastric junction)
  • [SCI] (Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study)
  • [SCI] (Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study)
  • [SCI] (Current status of liver diseases in Korea: hepatitis B)
  • [SCI] (Terlipressin-induced hyponatremic seizure)
  • [SCI] (Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations)
  • [SCI] (Dynamic changes in liver stiffness during the course of acute hepatitis A)
  • [SCI] (Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B)
  • [SCI] (Two cases of toxic hepatitis caused by arrowroot juice)
  • [SCI] (Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia)
  • [SCI] (Changes in liver stiffness after acute or chronic liver injury due to viral hepatitis--does fibrosis exist after recovery from acute viral hepatitis?)
  • [SCI] (Korean Liver Cancer Study Group. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma)
  • [SCI] (Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels)
  • [SCI] (Clinical characteristics of chronic pancreatitis according to the history of pancreatitis)
  • [SCI] (A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy)
  • [SCI] (Serum alanine aminotransferase level alone may not accurately represent necro-inflammation in patients with acute hepatitis)
  • [SCI] (Hepatitis B virus genetic diversity and mutant)
  • [SCI] (Laparoscopic resection of HCC implanted in the peritoneal cavity: a case detected by PET after hepatic resection)
  • [SCI] (Durability of antiviral response in HBeAg-positive chronic hepatitis B patients who maintained virologic response for one year after lamivudine discontinuation)
  • [SCI] (A case of systemic amyloidosis with pancreatic involvement mimicking autoimmune pancreatitis)
  • [SCI] (Clinical features of acute hepatitis A in recent two years)
  • [SCI] (Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization)
  • [국내논문] (Analysis of the factors that affect the mortality rate in severe acute pancreatitis)
  • [국외논문] (Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea, 2005-2006)
  • [국내논문] (Problems faced by Korean patients with chronic liver disease and the role of the Korean Association for the Study of the Liver--emphases on social discrimination, insufficiency of reimbursement coverage, and deficiency of the welfare system)
  • [국내논문] (Management of antiviral-resistant chronic hepatitis B virus infection)
  • [국외논문] (Durability of Antiviral Response in HBeAg-Positive Chronic Hepatitis B Patients Who Maintained Virologic Response for One Year After Lamivudine Discontinuation)
  • [국외논문] (Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study)
  • [국외논문] (Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment)
  • [국외논문] (Efficacy of Helicobacter pylori eradication therapy in chronic liver disease)
  • [국외논문] (Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea)
  • [국외논문] (Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy)
  • [국외논문] (A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA)
  • [국외논문] (Evolution of multi-drug resistant hepatitis B virus during sequential therapy)
  • [국외논문] (Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005)
  • [국외논문] (Is cytokeratin immunoreactivity useful in the diagnosis of short-segment Barretts oesophagus in Korea?)
  • [국외논문] (Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy)
  • [SCI] (Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade)
  • [SCI] (Small bowel pseudomelanosis associated with oral iron therapy)

기타

more
  • 2010, 2011, 2012년 Marquis Who’s Who 등재

최종수정일 : 2017.06.05